scholarly journals Molecular typing of Mycobacterium tuberculosis strains: a fundamental tool for tuberculosis control and elimination

2016 ◽  
Vol 8 (2) ◽  
Author(s):  
Angela Cannas ◽  
Antonio Mazzarelli ◽  
Antonino Di Caro ◽  
Giovanni Delogu ◽  
Enrico Girardi

Tuberculosis (TB) is still an important cause of morbidity and mortality worldwide. An improvement of the strategies for disease control is necessary in both low- and high-incidence TB countries. Clinicians, epidemiologists, laboratory specialists, and public health players should work together in order to achieve a significant reduction in TB transmission and spread of drug-resistant strains. Effective TB surveillance relies on early diagnosis of new cases, appropriate therapy, and accurate detection of outbreaks in the community, in order to implement proper TB control strategies. To achieve this goal, information from classical and molecular epidemiology, together with patient clinical data need to be combined. In this review, we summarize the methodologies currently used in molecular epidemiology, namely molecular typing. We will discuss their efficiency to phylogenetically characterize <em>Mycobacterium</em> <em>tuberculosis</em> isolates, and their ability to provide information that can be useful for disease control. We will also introduce next generation sequencing as the methodology that potentially could provide in a short time both, detection of new outbreaks and identification of resistance patterns. This could envision a potential of next generation sequencing as an important tool for accurate patient management and disease control.

2013 ◽  
Vol 57 (4) ◽  
pp. 378-380 ◽  
Author(s):  
Mayra Cruz-Rivera ◽  
Joseph C. Forbi ◽  
Lilian H.T. Yamasaki ◽  
Carlos A. Vazquez-Chacon ◽  
Armando Martinez-Guarneros ◽  
...  

Author(s):  
Daniel Zeitouni ◽  
Michael Catalino ◽  
Jordan Wise ◽  
Sean McCabe ◽  
Kathryn Pietrosimone ◽  
...  

BACKGROUND: Glioblastoma (GBM) is driven by various genomic alterations. Next generation sequencing (NGS) could yield targetable alterations that may impact outcomes. The goal of this study was to describe how NGS can inform targeted therapy (TT) in this patient population. METHODS: The medical records of patients (pts) with a diagnosis of GBM from 2017-2019 were reviewed. Records of patients with recurrent GBM and genomic alterations were evaluated. Objective response rates and disease control rates were deter-mined. RESULTS: A total of 87 pts with GBM underwent NGS. Forty percent (n = 35) were considered to have actionable alterations. Of the 35, 40% (n=14) pts had their treatment changed due to an alteration. The objective response rate (ORR) of this population was 43%. The disease control rate (DCR) was 100%. The absolute mean decrease in contrast enhancing disease was 50.7% (95% CI 34.8 &ndash; 66.6). CONCLUSION: NGS for GBM, particularly in the recurrent setting, yields a high rate of actionable alterations. We observed a high ORR and DCR, reflecting the value of NGS in deciding on TT to match alterations that are likely to respond. In conclusion, patient selection and availability of NGS may impact outcomes in select pts with recurrent GBM.


2014 ◽  
Vol 28 (4) ◽  
pp. 177-186 ◽  
Author(s):  
Zhugong Liu ◽  
Meihong Liu ◽  
Teresita Mercado ◽  
Orieji Illoh ◽  
Richard Davey

Sign in / Sign up

Export Citation Format

Share Document